| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/23/2009 | US20090105215 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 04/23/2009 | US20090105204 Therapeutic Uses for Aminosterol Compounds |
| 04/23/2009 | US20090105197 Use of Sodium Channel Blocking Compounds and Aspirin in Manufacturing Drugs for Producing Analgesia Synergistically in Mammals |
| 04/23/2009 | US20090105163 Conjugates of Immune Cell Specific Macrolide Compounds with Anti-Inflammatory Compounds for Improved Cellular Targeting of Anti-Inflammatory Therapy |
| 04/23/2009 | US20090105128 Cannabinoid receptor targeted agent |
| 04/23/2009 | US20090105124 Heterocyclic modulators of tgr5 |
| 04/23/2009 | US20090104694 Isolation and transplantation of retinal stem cells |
| 04/23/2009 | US20090104259 Compositions and methods for sirna inhibition of angiogenesis |
| 04/23/2009 | US20090104255 Liposome Drug Delivery of Polycyclic, Aromatic, Antioxidant or Anti-Inflammatory Compounds |
| 04/23/2009 | US20090104234 Methods of treating chronic neurogenic inflammation using modified clostridial toxins |
| 04/23/2009 | US20090104200 Modulating inflammasome activity and inflammation in the central nervous system |
| 04/23/2009 | US20090104187 Novel Rabbit Antibody Humanization Methods and Humanized Rabbit Antibodies |
| 04/23/2009 | US20090104180 Using selectin/immunoglobulin fusion for quelling organ transplant rejection |
| 04/23/2009 | US20090104178 Chemokine binding activity of viral tnf receptors and related proteins |
| 04/23/2009 | US20090104150 Polymer conjugates of interferon Beta-1a and uses |
| 04/23/2009 | CA2704201A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | CA2702942A1 Organic compounds |
| 04/23/2009 | CA2702680A1 Combination analgesic employing opioid and neutral antagonist |
| 04/23/2009 | CA2702644A1 A3 adenosine receptor antagonists |
| 04/23/2009 | CA2702563A1 Cgrp antagonists |
| 04/23/2009 | CA2702503A1 Cgrp-antagonists |
| 04/23/2009 | CA2700243A1 New no-donor aspirin derivatives |
| 04/23/2009 | CA2697982A1 1,3,5-trisubstituted triazole derivative |
| 04/23/2009 | CA2694994A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | CA2678092A1 Bilayer composition for the sustained release of acetaminophen and tramadol |
| 04/22/2009 | EP2050750A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050453A1 Pharmaceutical combinations of meloxicam, tramadol and paracetamol |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2050438A1 Spherical crude granule and method for production thereof |
| 04/22/2009 | EP2049534A1 Pyrazolo (3, 4-b) pyridine derivatives as pde4 inhibitors |
| 04/22/2009 | EP2049525A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 04/22/2009 | EP2049520A2 Indole compounds |
| 04/22/2009 | EP2049503A1 Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| 04/22/2009 | EP2049502A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 04/22/2009 | EP2049480A1 2-arylindole derivatives as npges-i inhibitors |
| 04/22/2009 | EP2049478A1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use |
| 04/22/2009 | EP2049199A1 Compositions for the treatment of chronic degenerative inflammatory conditions |
| 04/22/2009 | EP2049134A2 Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
| 04/22/2009 | EP2049133A2 New eucalyptus extract, method of preparation and therapeutic uses thereof |
| 04/22/2009 | EP2049099A1 Compositions and methods for the treatment of mucositis |
| 04/22/2009 | EP2049090A1 Use of 5-ht7 receptor agonists for the treatment of pain |
| 04/22/2009 | EP2002842A9 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/22/2009 | EP1539761B1 6,7-dihydro-5h-pyrazolo¬1,2-a pyrazol-1-ones which control inflammatory cytokines |
| 04/22/2009 | EP1480630B1 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 04/22/2009 | EP1049459B1 Oral liquid compositions |
| 04/22/2009 | CN101415730A Compositions and methods of use for antibodies of c-Met |
| 04/22/2009 | CN101415685A Kinase inhibitors and methods of use thereof |
| 04/22/2009 | CN101415678A Benzo[F]isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists |
| 04/22/2009 | CN101415412A The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 04/22/2009 | CN101415410A The use of bupropion metabolites for the treatment of inflammatory disorders |
| 04/22/2009 | CN101412995A Polyethyleneglycol modified aprotinin and preparation thereof |
| 04/22/2009 | CN101412744A Anti-angiogenic compositions and methods of use thereof |
| 04/22/2009 | CN101412741A Composition with methylprednisolone palmitate as active component for treating local inflammation |
| 04/22/2009 | CN101411849A Medicament for treating lumbar muscle strain and preparation method thereof |
| 04/22/2009 | CN101411845A Cancer-suppressing analgesic medicament |
| 04/22/2009 | CN101411834A Chinese medicament for treating common cold and fever |
| 04/22/2009 | CN101411831A Medicament for treating low fever |
| 04/22/2009 | CN101411825A Antirheumatic medicinal liquor and method for preparing the same |
| 04/22/2009 | CN101411807A Health-care medicinal liquor with function for tonifying kidney and preparation method thereof |
| 04/22/2009 | CN101411799A Oral medicinal liquor for treating rheumatism and rheumatoid disease |
| 04/22/2009 | CN101411751A Powder for soaking foot and eliminating heat |
| 04/22/2009 | CN101411734A Method for treating hyperosteogeny |
| 04/22/2009 | CN101411718A Composition with antiinflammatory and bacteriostatic functions |
| 04/22/2009 | CN101411707A Pharmaceutical composition for treating rheumatoid arthritis |
| 04/22/2009 | CN101411702A Nefopam hydrochloride naproxen sodium compound sustained-release preparation and preparation method thereof |
| 04/22/2009 | CN101411699A Aceclofenac paracetamol tablet and preparation technique |
| 04/22/2009 | CN100480387C GBS toxin receptor |
| 04/22/2009 | CN100480370C Probiotics for gut neuromuscular functions |
| 04/22/2009 | CN100480241C Kukoline C ring modified derivative and synthesis method thereof |
| 04/22/2009 | CN100479862C Transporters and drug delivery system by using the same |
| 04/22/2009 | CN100479853C Stasis arthralgia and production thereof |
| 04/22/2009 | CN100479846C Vitamin C and Lonicera and Forsythia capsule |
| 04/22/2009 | CN100479839C Ointment for treating arthralgia-syndrome and analgesia |
| 04/22/2009 | CN100479834C Method for processing monkshood |
| 04/22/2009 | CN100479813C Preparation method of capsule possessing antiinflammation, releaving pain and anticancer function |
| 04/22/2009 | CN100479804C Tibet medicine lamivphlomis root injection preparation and preparing method thereof |
| 04/21/2009 | US7521471 CB1cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders |
| 04/21/2009 | US7521460 e.g. 3-[(2,4-Difluorophenyl)amino]-2-{[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-7-phenylthieno[2,3-b]pyridin-6(7H)-one; autoimmune, neurodegenerative disorders, antiinflammatory agent; p38 MAP kinase inhibitor |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521212 Method for producing oligopolysaccharides |
| 04/21/2009 | US7521068 For pulmonary and nasal drug administration |
| 04/21/2009 | US7521053 Angiopoietin-2 specific binding agents |
| 04/21/2009 | CA2400317C Improved paste formulations |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/21/2009 | CA2336902C Topical compositions comprising an opioid analgesic and an nmda antagonist |
| 04/16/2009 | WO2009049180A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | WO2009048474A1 2,7,9-substituted purinone derivatives for immunosuppression |
| 04/16/2009 | WO2009048123A1 Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof |
| 04/16/2009 | WO2009047935A1 Fine particles |
| 04/16/2009 | WO2009047904A1 Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient |
| 04/16/2009 | WO2009047903A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 04/16/2009 | WO2009047802A2 Novel colon targeted modified release bioadhesive formulation of 5-amino salicylic acid or its salts and metabolites thereof |
| 04/16/2009 | WO2009047801A1 Therapeutic combinations and compositions for the treatment of gastrointestinal disorders |
| 04/16/2009 | WO2009047359A1 Inhibitors of protein kinases |
| 04/16/2009 | WO2009047336A1 Phthalazine and pyrido [3,4-d] pyridaz ine compounds as h1 receptor antagonists |